HCPCS Level II Code Lookup
Look up official HCPCS Level II codes for products, supplies, drugs, equipment and services, or browse by letter family below.
- Current release
- October 2026 effective October 1, 2026
- Active codes
- 7,448 active codes
- Maintainer
- Maintained by CMS
Browse by Letter Family
8,769 codes, grouped by their leading letter.
J
- J9293 Injection, mitoxantrone hydrochloride, per 5 mg
- J9294 Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
- J9295 Injection, necitumumab, 1 mg
- J9296 Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297 Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
- J9299 Injection, nivolumab, 1 mg
- J9300 Injection, gemtuzumab ozogamicin, 5 mg Historical
- J9301 Injection, obinutuzumab, 10 mg
- J9302 Injection, ofatumumab, 10 mg
- J9303 Injection, panitumumab, 10 mg
- J9304 Injection, pemetrexed (pemfexy), 10 mg
- J9305 Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 Injection, pertuzumab, 1 mg
- J9307 Injection, pralatrexate, 1 mg
- J9308 Injection, ramucirumab, 5 mg
- J9309 Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 Injection, rituximab, 100 mg Historical
- J9311 Injection, rituximab 10 mg and hyaluronidase
- J9312 Injection, rituximab, 10 mg
- J9313 Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314 Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9315 Injection, romidepsin, 1 mg Historical
- J9316 Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317 Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318 Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319 Injection, romidepsin, lyophilized, 0.1 mg
- J9320 Injection, streptozocin, 1 gram
- J9321 Injection, epcoritamab-bysp, 0.16 mg
- J9322 Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323 Injection, pemetrexed ditromethamine, 10 mg
- J9324 Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325 Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9326 Injection, telisotuzumab vedotin-tllv, 1 mg
- J9328 Injection, temozolomide, 1 mg
- J9329 Injection, tislelizumab-jsgr, 1mg
- J9330 Injection, temsirolimus, 1 mg
- J9331 Injection, sirolimus protein-bound particles, 1 mg
- J9332 Injection, efgartigimod alfa-fcab, 2mg
- J9333 Injection, rozanolixizumab-noli, 1 mg
- J9334 Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340 Injection, thiotepa, 15 mg Historical
- J9341 Injection, thiotepa (tepylute), 1 mg
- J9342 Injection, thiotepa, not otherwise specified, 1 mg
- J9345 Injection, retifanlimab-dlwr, 1 mg
- J9347 Injection, tremelimumab-actl, 1 mg
- J9348 Injection, naxitamab-gqgk, 1 mg
- J9349 Injection, tafasitamab-cxix, 2 mg
- J9350 Injection, mosunetuzumab-axgb, 1 mg
- J9351 Injection, topotecan, 0.1 mg
- J9352 Injection, trabectedin, 0.1 mg Historical
- J9353 Injection, margetuximab-cmkb, 5 mg
- J9354 Injection, ado-trastuzumab emtansine, 1 mg
- J9355 Injection, trastuzumab, excludes biosimilar, 10 mg
- J9356 Injection, trastuzumab, 10 mg and hyaluronidase-oysk
- J9357 Injection, valrubicin, intravesical, 200 mg
- J9358 Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
- J9359 Injection, loncastuximab tesirine-lpyl, 0.075 mg
- J9360 Injection, vinblastine sulfate, 1 mg
- J9361 Injection, efbemalenograstim alfa-vuxw, 0.5 mg
- J9362 Injection, trabectedin, 0.01 mg
- J9370 Vincristine sulfate, 1 mg
- J9371 Injection, vincristine sulfate liposome, 1 mg Historical
- J9376 Injection, pozelimab-bbfg, 1 mg
- J9380 Injection, teclistamab-cqyv, 0.5 mg
- J9381 Injection, teplizumab-mzwv, 5 mcg
- J9382 Injection, zenocutuzumab-zbco, 1 mg
- J9390 Injection, vinorelbine tartrate, 10 mg
- J9393 Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
- J9394 Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
- J9395 Injection, fulvestrant, 25 mg
- J9400 Injection, ziv-aflibercept, 1 mg
- J9600 Injection, porfimer sodium, 75 mg
- J9601 Injection, linvoseltamab-gcpt, 1 mg
- J9999 Not otherwise classified, antineoplastic drugs
K
- K0001 Standard wheelchair
- K0002 Standard hemi (low seat) wheelchair
- K0003 Lightweight wheelchair
- K0004 High strength, lightweight wheelchair
- K0005 Ultralightweight wheelchair
- K0006 Heavy duty wheelchair
- K0007 Extra heavy duty wheelchair
- K0008 Custom manual wheelchair/base
- K0009 Other manual wheelchair/base
- K0010 Standard - weight frame motorized/power wheelchair
- K0011 Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking
- K0012 Lightweight portable motorized/power wheelchair
- K0013 Custom motorized/power wheelchair base
- K0014 Other motorized/power wheelchair base
- K0015 Detachable, non-adjustable height armrest, replacement only, each
- K0017 Detachable, adjustable height armrest, base, replacement only, each
- K0018 Detachable, adjustable height armrest, upper portion, replacement only, each
- K0019 Arm pad, replacement only, each
- K0020 Fixed, adjustable height armrest, pair
- K0037 High mount flip-up footrest, each
- K0038 Leg strap, each
- K0039 Leg strap, h style, each
- K0040 Adjustable angle footplate, each
- K0041 Large size footplate, each
- K0042 Standard size footplate, replacement only, each